Page last updated: 2024-10-30

lansoprazole and Adenomatous Polyposis Coli

lansoprazole has been researched along with Adenomatous Polyposis Coli in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, KB1
Bishop, PR1
Nowicki, MJ1
East, JE1
Vieth, M1
Rex, DK1

Reviews

1 review available for lansoprazole and Adenomatous Polyposis Coli

ArticleYear
Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance.
    Gut, 2015, Volume: 64, Issue:6

    Topics: Adenomatous Polyposis Coli; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Early Detection of Ca

2015

Other Studies

1 other study available for lansoprazole and Adenomatous Polyposis Coli

ArticleYear
Gastric Polyps—To Worry or Not?
    Journal of pediatric gastroenterology and nutrition, 2015, Volume: 61, Issue:2

    Topics: Adenomatous Polyposis Coli; Adolescent; Humans; Lansoprazole; Male; Peutz-Jeghers Syndrome; Polyps;

2015